GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS (IST:ONCSM) » Definitions » Interest Coverage

Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Interest Coverage : 0 (At Loss) (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Oncosem Onkolojik Sistemlernayi ve Ticaret AS Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Operating Income for the three months ended in Dec. 2024 was ₺-2.6 Mil. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Expense for the three months ended in Dec. 2024 was ₺-7.3 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage or its related term are showing as below:

IST:ONCSM' s Interest Coverage Range Over the Past 10 Years
Min: 0.27   Med: 6.08   Max: 26.96
Current: 0.35


IST:ONCSM's Interest Coverage is ranked worse than
98.63% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 16.34 vs IST:ONCSM: 0.35

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS Interest Coverage Historical Data

The historical data trend for Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Interest Coverage Chart

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
Get a 7-Day Free Trial 6.08 26.96 15.88 - 0.27

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.44 2.17 -

Competitive Comparison of Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage

For the Medical Devices subindustry, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage falls into.


;
;

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Expense was ₺-35.7 Mil. Its Operating Income was ₺9.5 Mil. And its Long-Term Debt & Capital Lease Obligation was ₺0.0 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2024 )/Interest Expense (A: Dec. 2024 )
=-1*9.486/-35.749
=0.27

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the three months ended in Dec. 2024, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Expense was ₺-7.3 Mil. Its Operating Income was ₺-2.6 Mil. And its Long-Term Debt & Capital Lease Obligation was ₺0.0 Mil.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS  (IST:ONCSM) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Oncosem Onkolojik Sistemlernayi ve Ticaret AS Interest Coverage Related Terms

Thank you for viewing the detailed overview of Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS Business Description

Traded in Other Exchanges
N/A
Address
Mutlukent Mah. 1988 Cad. No: 12, Cankaya, Ankara, TUR
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is specialized in the production of equipment and medical devices used in cancer treatment.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Headlines

No Headlines